ConductScience.org, home

Trial · NCT07892742

The Effects of Increased Water Intake on Muscle Function, Physical Performance, and Endocrine Regulation in Low-Drinking Older Adults

NCT07892742, Not applicable, Recruiting, Polytechnic University of Santarém

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Effects of Increased Water Intake on Muscle Function, Physical Performance, and Endocrine Regulation in Low-Drinking Older Adults. Trials, record NCT07892742. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892742

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Effects of Increased Water Intake on Muscle Function, Physical Performance, and Endocrine Regulation in Low-Drinking Older Adults
NCT number
NCT07892742
Status
Recruiting
Phases
Not applicable
Enrollment
78 participants, estimated
Lead sponsor
Polytechnic University of Santarém
Conditions
Dehydrated, Water-Electrolyte Imbalance, Malnutrition, Dehydration (Physiology)
Interventions
Water
First posted
2026-10-23
Last updated
2026-11-12

Source ClinicalTrials.gov

Registered outcomes35

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAbsolute and Relative Ankle Plantar-Flexion Peak ForceDay 1 (baseline) and Day 7 (post-intervention)
Absolute peak force (N) and relative peak force (N·kg-¹) during a seated maximal voluntary isometric plantar-flexion contraction of the dominant limb. The highest force value recorded across four trials will be used for analysis.
PrimaryRate of Force Development During Isometric Ankle Plantar-FlexionDay 1 (baseline) and Day 7 (post-intervention)
Rate of force development (RFD; N·s-¹) during maximal voluntary isometric plantar-flexion of the dominant limb, calculated over consecutive 50-ms intervals from contraction onset: 0-50, 50-100, 100-150, and 150-200 ms.
PrimaryRate of Force Development During Dynamic Ankle Plantar-FlexionDay 1 (baseline) and Day 7 (post-intervention)Rate of force development (N·s-¹) during a standing bilateral rapid calf-raise task, calculated as peak force (N) divided by time to peak force (s).
PrimaryExplosive Isometric Ankle Plantar-Flexion ForceDay 1 (baseline) and Day 7 (post-intervention)
Explosive force, expressed as the percentage of peak force (%F) attained at 50, 100, 150, and 200 ms following contraction onset during maximal voluntary isometric plantar-flexion of the dominant limb.
PrimaryPeak Force during the 5 repetition STSDay 1 (baseline) and Day 7 (post-intervention)Peak vertical ground reaction force (N) recorded during the concentric phase of each sit-to-stand repetition. The participant-level summary measure will be defined a priori.
PrimaryFatigue Index During the 30-Second Sit-to-Stand TestDay 1 (baseline) and Day 7 (post-intervention)Fatigue index calculated to quantify the decline in performance across successive sit-to-stand repetitions during the 30-s STS. The calculation method will be specified a priori.
PrimaryMean Power During the 30-Second Sit-to-Stand TestDay 1 (baseline) and Day 7 (post-intervention)Mean lower-limb muscle power during the 30-s STS, estimated using a previously validated equation.
SecondaryTime to Complete the First Five Sit-to-Stand RepetitionsDay 1 (baseline) and Day 7 (post-intervention)
Time (s) required to complete the first five sit-to-stand repetitions during the 30-s STS test, measured from the onset of the first repetition until completion of the fifth repetition. Only participants completing at least five repetitions will be included in this analysis.
SecondaryFunctional Lower-Limb PerformanceDay 1 (baseline) and Day 7 (post-intervention)Number of completed repetitions during the 30-second sit-to-stand test (30-s STS), performed from a 43-cm armless chair.
SecondaryChange in Handgrip strengthDay 1 (baseline) and Day 7 (post-intervention)
Handgrip strength will be assessed using a portable hand dynamometer (Jamar Plus+). Participants will perform three maximal voluntary isometric contractions with each hand alternately. A 60-second rest period will be provided between attempts. The highest recorded value will be used for analysis. The outcome will be expressed as the change in handgrip strength from baseline to the post-intervention assessment.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers21

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
7943214BACKGROUNDPubMed
8150304BACKGROUNDPubMed
8169336BACKGROUNDPubMed
11528342BACKGROUNDPubMed
16028569BACKGROUNDPubMed
18617629BACKGROUNDPubMed
21853264BACKGROUNDPubMed
21994426BACKGROUNDPubMed
24728141BACKGROUNDPubMed
26255759BACKGROUNDPubMed

1 to 10 of 21

See all 21 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07892742

GET https://conductscience.org/api/trials/v1/NCT07892742/registered?page=2